Going for Hair Dye or Chemical Straigthening? Beware of Breast Cancer risks, says study

Published On 2019-12-04 14:40 GMT   |   Update On 2019-12-04 14:40 GMT

Chemical treatments used in hair dye or to permanently or semi-permanently straighten or relax hair (referred to as straighteners) contain a mixture of chemicals, including formulations that contain the carcinogen formaldehyde as an active ingredient.


USA: Products such as hair dye and hair straightener are widely used. Now a recent study in the International Journal of Cancer has found a link between frequent use of these chemical hair products and breast cancer risk. The findings are of deep concern keeping in mind the increasing use of such products by women.


Hair products are known to contain more than 5,000 chemicals including some having mutagenic and endocrine-disrupting properties. Some dye constituents such as 2,4-diaminoanisole sulfate and para-phenylenediamine have been found to induce tumours in the mammary glands of rats.


Chemical treatments used to permanently or semi-permanently straighten or relax hair (referred to as straighteners) contain a mixture of chemicals, including formulations that contain the carcinogen formaldehyde as an active ingredient.


Prior studies on the association of hair dye use and breast cancer have yielded inconsistent results. While some established a positive relationship, many concluded that there is no elevated risk.


Alexandra J. White, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, and colleagues evaluated the relationship specifically between breast cancer risk and hair dye and chemical straightener use in a prospective cohort of women ages 35-74.


For the purpose, the researchers used data from 46,709 women in the Sister Study who were enrolled between 2003 and 2009. The women had a sister with breast cancer but were cancer-free themselves. Enrollment questionnaires included past 12‐month hair product use.


Read Also: Hormonal contraceptives, hair dyes linked to increased breast cancer risk


Key findings of the study include:




  • During follow‐up (mean = 8.3 years), 2,794 breast cancers were identified. Fifty‐five per cent of participants reported using permanent dye at enrollment.

  • Permanent dye use was associated with 45% higher breast cancer risk in black women (HR = 1.45), and a 7% higher risk in white women (HR = 1.07).

  • Among all participants, personal straightener use was associated with breast cancer risk (HR = 1.18); with higher risk associated with increased frequency.

  • Nonprofessional application of semipermanent dye (HR = 1.28) and straighteners (HR = 1.27) to others was associated with breast cancer risk.

  • A higher breast cancer risk was associated with any straightener use and personal use of permanent dye, especially among black women.


Read Also: Dreadful hair dye reaction: Head doubled with breath panting

The researchers found that women who used hair straighteners at least every 5 to 8 weeks were about 30% more likely to develop breast cancer. While the association between straightener use and breast cancer was similar in African American and white women, straightener use was much more common among African American women.




Co-author Dale Sandler, PhD, chief of the NIEHS Epidemiology Branch, cautioned that although there is some prior evidence to support the association with chemical straighteners, these results need to be replicated in other studies.


When asked if women should stop dyeing or straightening their hair, Sandler said, "We are exposed to many things that could potentially contribute to breast cancer, and it is unlikely that any single factor explains a woman’s risk. While it is too early to make a firm recommendation, avoiding these chemicals might be one more thing women can do to reduce their risk of breast cancer."


The study, "Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women," is published in the International Journal of Cancer.


DOI: https://doi.org/10.1002/ijc.32738



Article Source : International Journal of Cancer

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News